Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs Astrid A.M. Van der Veldt, Mark Lubberink, Idris Bahce, Maudy Walraven, Michiel P. de Boer, Henri N.J.M. Greuter, N. Harry Hendrikse, Jonas Eriksson, Albert D. Windhorst, Pieter E. Postmus, Henk M. Verheul, Erik H. Serné, Adriaan A. Lammertsma, Egbert F. Smit Cancer Cell Volume 21, Issue 1, Pages (January 2012) DOI: /j.ccr Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
Figure 1 Cancer Cell , 82-91DOI: ( /j.ccr ) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
Figure 2 Cancer Cell , 82-91DOI: ( /j.ccr ) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
Figure 3 Cancer Cell , 82-91DOI: ( /j.ccr ) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
Figure 4 Cancer Cell , 82-91DOI: ( /j.ccr ) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
Figure 5 Cancer Cell , 82-91DOI: ( /j.ccr ) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions
Figure 6 Cancer Cell , 82-91DOI: ( /j.ccr ) Copyright © 2012 Elsevier Inc. Terms and Conditions Terms and Conditions